Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2/Phase 3
NCT04559139
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
- NCT04559139 ↗
- Active, not recruiting
- ECOG-ACRIN Cancer Research Group
- Focused
We haven't built an HCP commentary report on NCT04559139 (gemcitabine hydrochloride and cisplatin in Stage II Gallbladder Cancer AJCC v8) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT04559139 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 4 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial
- Phase
- Phase 2/Phase 3
- Status
- Active, not recruiting
- Conditions
- Stage II Gallbladder Cancer AJCC v8; Stage IIA Gallbladder Cancer AJCC v8; Stage IIB Gallbladder Cancer AJCC v8; Stage III Gallbladder Cancer AJCC v8; Stage IIIA Gallbladder Cancer AJCC v8; Stage IIIB Gallbladder Cancer AJCC v8
- Interventions
- Cisplatin; Gemcitabine Hydrochloride; Lymphadenectomy; Partial Hepatectomy
- Arms
- Arm I (surgery, adjuvant therapy) · Active comparator
- Arm II (neoadjuvant therapy, surgery, adjuvant therapy) · Experimental
- Enrollment
- 186 (estimated)
- Primary outcomes
- Difference in overall survival
- Sponsor
- ECOG-ACRIN Cancer Research Group with National Cancer Institute (NCI)
- Start
- Feb 24, 2021
- Primary completion
- Jul 1, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT04559139 · updated Oct 19, 2026